litlas
Log inCreate account

Michael J. Cork

Active 1986–2025

118
Papers
20,381
Citations
72
h-index
110
i10-index

Citations

Citations per year for Michael J. Cork1964: 1 citations1986: 11 citations1987: 1 citations1993: 3 citations1994: 6 citations1995: 6 citations1996: 20 citations1997: 18 citations1998: 32 citations1999: 20 citations2000: 38 citations2001: 20 citations2002: 31 citations2003: 15 citations2004: 18 citations2005: 12 citations2006: 43 citations2007: 34 citations2008: 44 citations2009: 59 citations2010: 45 citations2011: 80 citations2012: 95 citations2013: 122 citations2014: 107 citations2015: 122 citations2016: 95 citations2017: 154 citations2018: 175 citations2019: 591 citations2020: 763 citations2021: 845 citations2022: 681 citations2023: 679 citations2024: 1,047 citations2025: 552 citations2026: 9 citations1965–1985: no citations, so these years are not shown1988–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,695 citing papers, 18.6% of this breakdownUnited Kingdom: 832 citing papers, 9.1% of this breakdownGermany: 713 citing papers, 7.8% of this breakdownItaly: 463 citing papers, 5.1% of this breakdownChina: 408 citing papers, 4.5% of this breakdownFrance: 391 citing papers, 4.3% of this breakdownCanada: 373 citing papers, 4.1% of this breakdownJapan: 364 citing papers, 4% of this breakdownNetherlands: 322 citing papers, 3.5% of this breakdownSpain: 282 citing papers, 3.1% of this breakdownSwitzerland: 257 citing papers, 2.8% of this breakdownDenmark: 249 citing papers, 2.7% of this breakdown
0%18.6%Other 30.4%

Institutions

Fields

  • Medicine73.4%
  • Immunology and Microbiology13.1%
  • Biochemistry, Genetics and Molecular Biology6.4%
  • Pharmacology, Toxicology and Pharmaceutics2.5%
  • Health Professions1.6%
  • Neuroscience0.8%
  • Other2.2%

Topics

  • Dermatology and Skin Diseases18.6%
  • Allergic Rhinitis and Sensitization8.7%
  • Psoriasis: Treatment and Pathogenesis7.9%
  • Asthma and respiratory diseases6.6%
  • Food Allergy and Anaphylaxis Research3.9%
  • Urticaria and Related Conditions3.1%
  • Other51.2%

Coauthors

All papers

Open in search
  1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Authors: Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - New England Journal of Medicine 2016 cited by 2,045

  2. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    Authors: Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky, Margitta Worm, Charles Lynde, J.‐P. Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Yves Poulin, Aleksandra Lesiak, Leon Kircik, S.H. Cho, Pedro Herranz, Michael J. Cork, Ketty Peris, Louise Abildgaard Steffensen, B K Bang, Alexandra Kuznetsova, T.N. Jensen, Marie Louise Østerdal, Eric L. Simpson, the ECZTRA 1 and ECZTRA 2 study investigators - British Journal of Dermatology 2020 cited by 595

  3. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Weily Soong, Mercedes E. González, Lynda C. Schneider, Robert Sidbury, Benjamin Lockshin, Steven M Meltzer, Zhixiao Wang, Leda Mannent, Nikhil Amin, Yiping Sun, Elizabeth Laws, Bolanle Akinlade, Myles Dillon, Matthew P. Kosloski, Mohamed Kamal, Ariane Dubost-Brama, Naimish Patel, David M. Weinreich, George D. Yancopoulos, John T. O’Malley, Ashish Bansal, A. Pepper, Amy S. Paller, Benjamin Lockshin, David J. Cohen, David M. Pariser, Elaine C. Siegfried, Eric L. Simpson, Jeffrey Leflein, Jeffrey S. Weinberg, John Browning, Joyce Teng, Lara Wine Lee, Lawrence Sher, Lucia Z. Diaz, Lynda C. Schneider, Mercedes E. González, Ned T. Rupp, Peck Y. Ong, Robert Cartwright, Robert Sidbury, Weily Soong, Andreas Pinter, Andreas Wollenberg, Christina Schnopp, Michael J. Cork, Peter D. Arkwright, Anna Korkosz, Dorota Bystrzanowska, Ewa Sygula, Jacek Zdybski, Kamila Padlewska - The Lancet 2022 cited by 264

  4. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

    Authors: Andreas Wollenberg, Stéphanie Christen-Zäch, Alain Taı̈eb, C. Paul, Jacob P. Thyssen, Marjolein de Bruin‐Weller, Christian Vestergaard, Julien Sénéschal, Thomas Werfel, Michael J. Cork, B Kunz, Regina Fölster‐Holst, Magdalena Trzeciak, Ulf Darsow, Zsuzsanna Szalai, Mette Deleuran, Laura von Kobyletzki, S. Barbarot, Annice Heratizadeh, Uwe Gieler, DirkJan Hijnen, Stephan Weidinger, L. De Raeve, Åke Svensson, Dagmar Simon, J.‐F. Stalder, Johannes Ring, for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force - Journal of the European Academy of Dermatology and Venereology 2020 cited by 465

  5. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

    Authors: Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Lisa A. Beck, Mark Boguniewicz, Lawrence Sher, Jamie Weisman, John T. O’Malley, Naimish Patel, Megan Hardin, Neil M.H. Graham, Marcella Ruddy, Xian Sun, John D. Davis, Mohamed Kamal, Faisal A. Khokhar, David M. Weinreich, George D. Yancopoulos, Bethany Beazley, Ashish Bansal, Brad Shumel - Journal of the American Academy of Dermatology 2020 cited by 389

  6. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: Eric L. Simpson, Rodney Sinclair, Seth Forman, Andreas Wollenberg, Roland Aschoff, Michael J. Cork, Thomas Bieber, Jacob P. Thyssen, Gil Yosipovitch, Carsten Flohr, Nina Magnolo, Catherine Maari, Claire Feeney, Pinaki Biswas, Svitlana Tatulych, Hernán Valdez, Ricardo Rojo - The Lancet 2020 cited by 491

  7. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis

    Authors: Lisa A. Beck, Michael J. Cork, Masayuki Amagai, Anna De Benedetto, Kenji Kabashima, Jennifer D. Hamilton, Ana B. Rossi - JID Innovations 2022 cited by 226

  8. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

    Authors: Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith, Kristian Reich, Michael J. Cork, Allen Radin, Q. Zhang, Bolanle Akinlade, A. Gadkari, Laurent Eckert, Thomas Hultsch, Z. Chen, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel - British Journal of Dermatology 2017 cited by 475

  9. Conjunctivitis in dupilumab clinical trials

    Authors: Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller, Eric L. Simpson, Andrew Blauvelt, Michael J. Cork, Errol P. Prens, Penny A. Asbell, Esen K. Akpek, Jonathan Corren, Claus Bachert, Ikuo Hirano, Jonathan Weyne, Andrew Korotzer, Z. Chen, Thomas Hultsch, Xiaoping Zhu, John D. Davis, Leda Mannent, Jennifer D. Hamilton, Ariel Teper, Heribert Staudinger, E. Rizova, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel, Marius Ardeleanu, Andreas Wollenberg - British Journal of Dermatology 2019 cited by 422

  10. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

    Authors: Amy S. Paller, Carsten Flohr, Michael J. Cork, Anthony Bewley, Andrew Blauvelt, Hwanhee Hong, Shinichi Imafuku, Marie L. A. Schuttelaar, Eric L. Simpson, Weily Soong, Petra Arlert, Katja Wendicke Lophaven, Azra Kurbasic, Lise Soldbro, Natacha Strange Vest, Andreas Wollenberg - JAMA Dermatology 2023 cited by 137

  11. Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial

    Authors: Stephan Weidinger, Thomas Bieber, Michael J. Cork, Adam Reich, Rosamund Wilson, Sonia Quaratino, Marisa Stebegg, Nuala Brennan, Sally Gilbert, John T. O’Malley, Ben Porter‐Brown - British Journal of Dermatology 2023 cited by 104

  12. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial

    Authors: Joanne R Chalmers, Rachel Haines, Lucy Bradshaw, Alan Montgomery, Kim S Thomas, Sara Brown, Matthew J Ridd, Sandra Lawton, Eric L. Simpson, Michael J. Cork, Tracey Sach, Carsten Flohr, Eleanor Mitchell, Richard Swinden, Stella Tarr, Susan Davies‐Jones, Nicola Jay, Maeve Kelleher, Michael R. Perkin, Robert Boyle, Hywel C Williams - The Lancet 2020 cited by 309

  13. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

    Authors: Lam C. Tsoi, Sarah L. Spain, Jo Knight, Eva Ellinghaus, Philip E. Stuart, Francesca Capon, Jun Ding, Yanming Li, Trilokraj Tejasvi, Jóhann E. Guðjónsson, Hyun Min Kang, Michael H. Allen, Ross McManus, Giuseppe Novelli, Lena Samuelsson, Joost Schalkwijk, Mona Ståhle, A. David Burden, Catherine Smith, Michael J. Cork, Xavier Estivill, A. Bowcock, Gerald G. Krueger, Wolfgang Weger, Jane Worthington, Rachid Tazi‐Ahnini, Frank O. Nestlé, Adrian Hayday, Per Hoffmann, Juliane Winkelmann, Cisca Wijmenga, Cordelia Langford, Sarah Edkins, Robert Andrews, Hannah Blackburn, Amy Strange, Gavin Band, Richard D. Pearson, Damjan Vukcevic, Chris C. A. Spencer, Panos Deloukas, Ulrich Mrowietz, Stefan Schreiber, Stephan Weidinger, Sulev Kõks, Külli Kingo, Tõnu Esko, Andres Metspalu, Henry W. Lim, John J. Voorhees, Michael Weichenthal, H.‐Erich Wichmann, Vinod Chandran, Cheryl F. Rosen, Proton Rahman, Dafna D. Gladman, C.E.M. Griffiths, André Reis, Juha Kere, Rajan P. Nair, André Franke, Jonathan N W N Barker, Gonçalo R. Abecasis, James T Elder, Richard C. Trembath - Nature Genetics 2012 cited by 1,047

  14. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)

    Authors: Andrew Blauvelt, Emma Guttman‐Yassky, Amy S. Paller, Eric L. Simpson, Michael J. Cork, Jamie Weisman, John Browning, Weily Soong, Xian Sun, Zhen Chen, Matthew P. Kosloski, Mohamed Kamal, Dimittri Delevry, Chien‐Chia Chuang, John T. O’Malley, Ashish Bansal - American Journal of Clinical Dermatology 2022 cited by 120

  15. Adverse effects of topical glucocorticosteroids

    Authors: Ulrich R. Hengge, Thomas Ruzicka, Robert A. Schwartz, Michael J. Cork - Journal of the American Academy of Dermatology 2005 cited by 1,122

  16. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1

    Authors: Amy Strange, Gavin Band, Gavin Band, Matti Pirinen, Chris C. A. Spencer, Céline Bellenguez, Colin L. Freeman, Anna Rautanen, Zhan Su, Francesca Capon, Christopher G. Mathew, Michael E. Weale, Alexandros Onoufriadis, Richard C. Trembath, Michael H. Allen, Alexandros Onoufriadis, Jo Knight, Catherine Smith, Frank O. Nestlé, Richard C. Trembath, Jo Knight, Frank O. Nestlé, Anne Barton, Jane Worthington, Joost Schalkwijk, Patrick L.J.M. Zeeuwen, Judith G.M. Bergboer, Jenefer M. Blackwell, Elvira Bramon, Emma Gray, Suzannah J. Bumpstead, Sarah Hunt, Simon Potter, Sarah Edkins, Cordelia Langford, Leena Peltonen, Panos Deloukas, Juan P. Casas, Michael J. Cork, Rachid Tazi‐Ahnini, Aiden Corvin, Gilean McVean, Alexander Dilthey, Gil McVean, Loukas Moutsianas, Stephen Leslie, Audrey Duncanson, Xavier Estivill, Eva Riveira‐Muñoz, Brian Kirby, Oliver FitzGerald, Emiliano Giardina, Giuseppe Novelli, Wolfgang Weger, Angelika Hofer, Wolfgang Salmhofer, André Reis, Ulrike Hüffmeier, Alan D. Irvine, Janusz Jankowski, Jesús Lascorz, A. David Burden, Joyce Leman, Katarina Wolk, Lotus Mallbris, Mona Ståhle, Hugh S. Markus, W.H. Irwin McLean, Lena Samuelsson, Colin N A Palmer, Carlo Perricone, Robert Plomin, Rotraut Mößner, Åsa Torinsson Naluai, Lena Samuelsson, Heiko Traupe, Carlo Perricone, Robert Plomin, Ramón M. Pujol, Adrian Hayday, Stephen Sawcer, Juha Kere, Catherine Smith, Heiko Traupe - Nature Genetics 2010 cited by 1,058

  17. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention

    Authors: Eric L. Simpson, Joanne R Chalmers, Jon M. Hanifin, Kim S Thomas, Michael J. Cork, W.H. Irwin McLean, Sara Brown, Zunqiu Chen, Yiyi Chen, Hywel C Williams - Journal of Allergy and Clinical Immunology 2014 cited by 718

  18. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

    Authors: Eric L. Simpson, Marjolein de Bruin‐Weller, Carsten Flohr, Michael R. Ardern‐Jones, S. Barbarot, Mette Deleuran, Thomas Bieber, Christian Vestergaard, Sara Brown, Michael J. Cork, Aaron M. Drucker, Lawrence F. Eichenfield, R. Foelster‐Holst, Emma Guttman‐Yassky, Audrey Nosbaum, Nick J. Reynolds, Jonathan I. Silverberg, Jochen Schmitt, Marieke M.B. Seyger, Phyllis I. Spuls, Jean-Francois Stalder, John Su, Roberto Takaoka, Claudia Traidl‐Hoffmann, Jacob P. Thyssen, Jorien van der Schaft, Andreas Wollenberg, Alan D. Irvine, Amy S. Paller - Journal of the American Academy of Dermatology 2017 cited by 236

  19. Epidermal Barrier Dysfunction in Atopic Dermatitis

    Authors: Michael J. Cork, Simon G. Danby, Yiannis Vasilopoulos, Jonathan Hadgraft, Majella E. Lane, Manar Moustafa, Richard H. Guy, Alice MacGowan, Rachid Tazi‐Ahnini, Simon Ward - Journal of Investigative Dermatology 2009 cited by 756

  20. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018

    Authors: John R Ingram, Fiona Collier, D. Brown, T. Burton, John Burton, M.F. Chin, Neel Desai, Tim Goodacre, Vincent Piguet, Andrew Pink, L.S. Exton, M.F. Mohd Mustapa, N.J. Levell, P.M. McHenry, T.A. Leslie, S. H. Wakelin, R.Y.P. Hunasehally, Michael J. Cork, G.A. Johnston, F.S. Worsnop, Pariyawan Rakvit, Asad Salim, Bryan McDonald, D.A. Buckley, Ser‐Ling Chua, Gabriela Petrof, N. Callachand, T. Flavell, A.A. Salad - British Journal of Dermatology 2018 cited by 177

  21. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis

    Authors: Simon G. Danby, Paul Andrew, Rosie Taylor, Linda J. Kay, John Chittock, Abigail Pinnock, Intisar Ulhaq, Anna Fasth, Karin Carlander, Tina Holm, Michael J. Cork - Clinical and Experimental Dermatology 2022 cited by 65

  22. Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase II a open‐label trial and subsequent phase III open‐label extension

    Authors: Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Thomas Hultsch, John D. Davis, Y. Zhang, Xiaoping Zhu, Z. Chen, M. Li, Marius Ardeleanu, Ariel Teper, Bolanle Akinlade, A. Gadkari, Laurent Eckert, Mohamed Kamal, M. Ruddy, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, A. Thomas DiCioccio, Ashish Bansal - British Journal of Dermatology 2019 cited by 145

  23. A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy

    Authors: Amy S. Paller, Elaine C. Siegfried, Eric L. Simpson, Michael J. Cork, B. Lockshin, Matthew P. Kosloski, Mohamed Kamal, John D. Davis, Xun Sun, Gianluca Pirozzi, Neil M.H. Graham, A. Gadkari, Laurent Eckert, M. Ruddy, Ashish Bansal - Journal of the European Academy of Dermatology and Venereology 2020 cited by 87

  24. Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema‐prone skin*

    Authors: Simon G. Danby, Paul Andrew, Linda J. Kay, Abigail Pinnock, John Chittock, Kirsty Brown, Samuel F. Williams, Michael J. Cork - British Journal of Dermatology 2021 cited by 75